Invested $40 million in D3 Bio to advance its oncology pipeline.
D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology
D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. The company aims to create breakthrough precision medicines that match therapies to the disease biomarkers of individual patients.